Related Experiment Video
Updated: Jun 30, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
Congenital hypoganglionosis: phenotype-based outcomes and evolution of diagnosis and management-a systematic review
Hiroki Nakamura1, Hiroshi Yamakawa1, Nozomi Aoki1
1Department of Pediatric Surgery, Kansai Medical University, Osaka, Japan.
Insights
Congenital hypoganglionosis (CH) extent impacts outcomes. Diffuse neonatal CH has high mortality, while colon-limited CH shows favorable survival. Diagnostic advances aid phenotype-based management.
Area of Science:
- Pediatric Gastroenterology
- Neurogastroenterology
- Enteric Neuropathies
Background:
- Congenital hypoganglionosis (CH) is a rare enteric neuropathy.
- It is characterized by reduced and small ganglion cells in the myenteric plexus.
- Understanding CH clinical outcomes and diagnostic evolution in children is crucial.
Purpose of the Study:
- To systematically review the clinical outcomes of CH in pediatric patients.
- To analyze the diagnostic evolution of CH.
- To stratify CH based on disease extent and its impact on survival.
Main Methods:
- Systematic review following PRISMA guidelines.
- Searched PubMed and Web of Science (1978-2025).
- Analyzed 32 studies including 298 pediatric patients, classifying disease extent.
Main Results:
- Diffuse/panintestinal CH (48%) had high mortality (26.7% in neonates), while colon-limited CH (8%) had no reported deaths.
- Most diffuse cases presented neonatally.
- Diagnostic methods evolved, with increased HuC/D staining post-2020, and surgical management shifted to phenotype-based strategies.
Conclusions:
- Diffuse neonatal CH is associated with high mortality; colon-limited CH has favorable survival.
- Advanced diagnostics support phenotype-based management.
- Extent-based stratification may improve outcomes in severe CH cases.
Purpose:
Congenital hypoganglionosis (CH) is a rare enteric neuropathy characterized by reduced and small ganglion cells in the myenteric plexus. We aimed to systematically review the clinical outcomes and diagnostic evolution of CH in children.
Methods:
A systematic review was conducted in accordance with PRISMA guidelines using PubMed and Web of Science (1978-2025). Of 396 identified records, 32 studies including 298 pediatric patients were analyzed. Disease extent was classified as diffuse/panintestinal, colon-limited, segmental, or unspecified.
Results:
Among 298 patients, 144 (48%) were classified as diffuse/panintestinal, 25 (8%) as colon-limited, 22 (7%) as segmental, and 107 (36%) were unspecified. Among patients with diffuse/panintestinal disease for whom mortality data were available (n = 105), 28 deaths (26.7%) were documented, whereas no deaths were reported in colon-limited cases (0/24). Most diffuse cases presented in the neonatal period. Diagnostic methods evolved over time, with increasing use of quantitative HuC/D staining after 2020. Surgical management also shifted from resection-based procedures to phenotype-based strategies, including stoma formation and intestinal rehabilitation.
Conclusion:
Diffuse or panintestinal neonatal forms are associated with high mortality, whereas colon-limited disease is associated with favorable survival. Advances in diagnostic techniques have supported phenotype-based management. Extent-based stratification may improve outcomes in severe cases.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
